We are the Stoner Pharm Dispensary team and pilotting cannabis and cannabis products from place to place is our sole responsibility. We take pride in knowing that we do not just grow the herb but also make sure it gets to whoever needs it. After all production is NOT complete until the product reaches the final consumer
Worldwide shipping destinations
Smell proof packaging
Seven days refund policy
We were born out of our love for cannabis and the health benefits of the cannabinoids and other medicinal components found in th herb. We started in 2009 just as a social medai forum recommending cannabis forums for travellers all around world.We grew all our products indoor and in a confined and temperature regulated environent making all our products top shop, indoor grown and of high level of THC content which mde our social media pages boosting with likes an shares. After over 8 months of adovatiing and supporting the porject in our own way, we had the testimony from Lindsey Vilvan of how our products helped helped her 3 years old son with seizures and also testimonies from different clients with cancer and other illnesses. Basically we can say ” we were born out of our pure passion for what cannabis can do ” and we hope to promote the product to the end
Cannabis and Cancer
Cannabis, also known as marijuana, originated in Central Asia but is grown worldwide today. In the United States, it is a controlled substance and is classified as a Schedule I agent (a drug with a high potential for abuse, and no currently accepted medical use). The Cannabis plant produces a resin containing psychoactive compounds called cannabinoids, in addition to other compounds found in plants, such as terpenes and flavonoids.
The highest concentration of cannabinoids is found in the female flowers of the plant. Clinical trials conducted on medicinal Cannabis are limited. The U.S. Food and Drug Administration (FDA) has not approved the use of Cannabis as a treatment for any medical condition. To conduct clinical drug research with Cannabis in the United States, researchers must file an Investigational New Drug (IND) application with the FDA, obtain a Schedule I license from the U.S. Drug Enforcement Administration, and obtain approval from the National Institute on Drug Abuse.